X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/car-t-death-drives-lyell-take-2-track-approach-dose-escalation
https://www.globenewswire.com/news-release/2024/06/26/2904373/0/en/Lyell-Immunopharma-Reports-Dose-dependent-Clinical-Activity-from-Phase-1-Trial-of-LYL797-a-ROR1-targeted-CAR-T-Cell-Product-Candidate-Enhanced-with-its-Proprietary-Anti-exhaustion-.html
https://www.globenewswire.com/news-release/2024/06/03/2892587/0/en/Lyell-Immunopharma-to-Participate-in-the-Goldman-Sachs-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/06/2875772/0/en/Lyell-Immunopharma-Reports-Business-Highlights-and-Financial-Results-for-the-First-Quarter-2024.html
https://www.globenewswire.com/news-release/2024/05/07/2877204/0/en/Lyell-Immunopharma-to-Participate-in-BofA-Securities-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/03/05/2840940/0/en/Lyell-Immunopharma-Announces-the-Acceptance-of-Three-Abstracts-for-Presentation-at-2024-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/28/2837424/0/en/Lyell-Immunopharma-Reports-Business-Highlights-and-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2023.html
https://www.globenewswire.com//news-release/2024/02/26/2835480/0/en/Lyell-Immunopharma-Announces-Participation-in-March-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/03/2803611/0/en/Lyell-Immunopharma-to-Participate-in-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/09/2777799/0/en/Lyell-Immunopharma-Receives-FDA-Orphan-Drug-Designation-for-LYL845-for-the-Treatment-of-Melanoma.html
Market Place
Share 
